Royal Caribbean Cruises sell BiotechBee
Start price
21.09.22
/
70%
€47.73
Target price
31.12.24
€39.00
Performance (%)
-2.79%
End price
02.01.23
€46.40
Summary
This prediction ended on 02.01.23 with a price of €46.40. With a performance of -2.79%, the SELL prediction by BiotechBee was trending in the right direction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Royal Caribbean Cruises | -1.156% | -1.156% | 8.415% | 435.464% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% | 47.267% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% | 68.687% |
According to BiotechBee what are the pros and cons of Royal Caribbean Cruises for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Royal Caribbean Cruises diskutieren
Sell mit Kursziel 39,0